Physician Data Query

Last uploaded: January 31, 2024
Preferred Name

nimodipine

Synonyms

NIMO

Definitions

A dihydropyridine derivative and an analogue of the calcium channel blocker nifedipine, with antihypertensive activity. Nimodipine inhibits the transmembrane influx of calcium ions in response to depolarization in smooth muscle cells, thereby inhibiting vascular smooth muscle contraction and inducing vasodilatation. Nimodipine has a greater effect on cerebral arteries than on peripheral smooth muscle cells and myocardial cells, probably because this agent can cross the blood brain barrier due to its lipophilic nature. Furthermore, this agent also inhibits the drug efflux pump P-glycoprotein, which is overexpressed in some multi-drug resistant tumors, and may improve the efficacy of some antineoplastic agents. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C692" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C692" NCI Thesaurus)

ID

http://purl.bioontology.org/ontology/PDQ/CDR0000041210

altLabel

NIMO

Nimotop

CAS Registry

66085-59-4

Component of

http://purl.bioontology.org/ontology/PDQ/CDR0000041224

http://purl.bioontology.org/ontology/PDQ/CDR0000041215

cui

C0028094

C0678207

Date last modified

2006-12-12

definition

A dihydropyridine derivative and an analogue of the calcium channel blocker nifedipine, with antihypertensive activity. Nimodipine inhibits the transmembrane influx of calcium ions in response to depolarization in smooth muscle cells, thereby inhibiting vascular smooth muscle contraction and inducing vasodilatation. Nimodipine has a greater effect on cerebral arteries than on peripheral smooth muscle cells and myocardial cells, probably because this agent can cross the blood brain barrier due to its lipophilic nature. Furthermore, this agent also inhibits the drug efflux pump P-glycoprotein, which is overexpressed in some multi-drug resistant tumors, and may improve the efficacy of some antineoplastic agents. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C692" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C692" NCI Thesaurus)

Legacy PDQ ID

4283

LT

TRD

NCI ID

C692

notation

CDR0000041210

ORIG STY

Drug/agent

prefLabel

nimodipine

tui

T109

T121

Delete Subject Author Type Created
No notes to display
Create mapping

Delete Mapping To Ontology Source
http://purl.bioontology.org/ontology/SNOMEDCT/87285001 SNOMEDCT CUI
http://purl.bioontology.org/ontology/MESH/D009553 MESH CUI
http://purl.bioontology.org/ontology/VANDF/4019390 VANDF CUI
http://purl.bioontology.org/ontology/SNOMEDCT/387502003 SNOMEDCT CUI
http://purl.bioontology.org/ontology/MESH/D009553 MESH CUI
http://purl.bioontology.org/ontology/SCTSPA/87285001 SCTSPA CUI
http://purl.bioontology.org/ontology/NDFRT/N0000147543 NDFRT CUI
http://purl.bioontology.org/ontology/ATC/C08CA06 ATC CUI
http://purl.bioontology.org/ontology/CSP/4005-0039 CRISP CUI
http://purl.bioontology.org/ontology/SNMI/C-815B0 SNMI CUI
http://purl.bioontology.org/ontology/MSHFRE/D009553 MSHFRE CUI
http://purl.bioontology.org/ontology/NDDF/000713 NDDF CUI
http://purl.bioontology.org/ontology/RXNORM/7426 RXNORM CUI
http://purl.bioontology.org/ontology/RCD/dt1.. RCD CUI
http://purl.bioontology.org/ontology/SCTSPA/387502003 SCTSPA CUI
http://purl.bioontology.org/ontology/NDFRT/N0000006560 NDFRT CUI
http://purl.bioontology.org/ontology/RCD/x02ku RCD CUI
http://purl.bioontology.org/ontology/RXNORM/196516 RXNORM CUI
http://purl.obolibrary.org/obo/NCIT_C692 BERO LOOM
http://purl.bioontology.org/ontology/VANDF/4019390 VANDF LOOM
http://scai.fraunhofer.de/AlzheimerOntology#Nimodipine ADO LOOM
http://purl.obolibrary.org/obo/OMIT_0010575 OMIT LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#D03.383.725.203.570 RH-MESH LOOM
http://purl.bioontology.org/ontology/SNOMEDCT/387502003 SNOMEDCT LOOM
http://purl.bioontology.org/ontology/MESH/D009553 MESH LOOM
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C692 NCIT LOOM
http://doe-generated-ontology.com/OntoAD#C0028094 ONTOAD LOOM
http://purl.obolibrary.org/obo/MESH_D009553 BERO LOOM
http://purl.bioontology.org/ontology/NDFRT/N0000147543 NDFRT LOOM
http://purl.jp/bio/4/id/200906049298138498 IOBC LOOM
http://sbmi.uth.tmc.edu/ontology/ochv#8722 OCHV LOOM
http://www.co-ode.org/ontologies/galen#Nimodipine GALEN LOOM
http://www.drugbank.ca/drugs/DB00393 FTC LOOM
http://purl.bioontology.org/ontology/ATC/C08CA06 ATC LOOM
http://stirdf.jst.go.jp/id/200907003206447655 IOBC LOOM
http://purl.bioontology.org/ontology/CSP/4005-0039 CRISP LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#D009553 RH-MESH LOOM
http://purl.bioontology.org/ontology/SNMI/C-815B0 SNMI LOOM
http://evs.nci.nih.gov/ftp1/NDF-RT/NDF-RT.owl#N0000147543 OCVDAE LOOM
http://www.ustb.edu.cn/thesauri/tocr/v1/data#C571353432175145023 ACVD_ONTOLOGY LOOM
http://www.phoc.org.cn/pmo/class/PMO_00018329 PMAPP-PMO LOOM
http://sbmi.uth.tmc.edu/ontology/ochv#C0028094 OCHV LOOM
https://go.drugbank.com/drugs/DB00393 MDM LOOM
http://purl.bioontology.org/ontology/NDDF/000713 NDDF LOOM
http://purl.bioontology.org/ontology/RXNORM/7426 RXNORM LOOM
http://purl.obolibrary.org/obo/CHEBI_7575 EFO LOOM
http://purl.obolibrary.org/obo/CHEBI_7575 PDRO LOOM
http://purl.obolibrary.org/obo/CHEBI_7575 FIDEO LOOM
http://purl.obolibrary.org/obo/CHEBI_7575 DINTO LOOM
http://purl.obolibrary.org/obo/CHEBI_7575 BERO LOOM
http://purl.obolibrary.org/obo/CHEBI_7575 DRON LOOM
http://purl.obolibrary.org/obo/CHEBI_7575 CHEBI LOOM
http://purl.bioontology.org/ontology/RCD/dt1.. RCD LOOM
http://www.semanticweb.org/ontologies/STO.owl#OWLClass_da88dd5f_3d51_47b3_a857_591ec6b75f77 STO-DRAFT LOOM
http://www.semanticweb.org/ontologies/STO.owl#OWLClass_da88dd5f_3d51_47b3_a857_591ec6b75f77 CVAO LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#D03.383.725.547.570 RH-MESH LOOM